0
Industry
Geography
Report Type
Themes
Price
Publication date
Published Date
  • Innovation Ranking

    $1,995 | March 2024
    Innovation Ranking

    Innovation Ranking – Cosmo Pharmaceuticals NV

    Cosmo Pharmaceuticals NV (Cosmo) is a pharmaceutical company. The company develops drugs for the treatment of gastrointestinal diseases and dermatology. It develops pharmaceutical products based on its multi-matrix technology. The company offer products such as Lialda, Mezavant, Mesavancol, and Uceris for the treatment of ulcerative colitis It also offers Eleview which is a submucosal injectable composition for use in gastrointestinal endoscopic procedures. Its manufacturing facility is located in Lainate, Milan. Cosmo is headquartered in Dublin, Ireland.

  • Innovation Ranking

    $1,995 | March 2024
    Innovation Ranking

    Innovation Ranking – Alembic Pharmaceuticals Ltd

    Alembic Pharmaceuticals Ltd (APL) is a pharmaceutical company that manufactures and supplies generic pharmaceutical products. The company's product portfolio includes oral solids, oncology OSD, general and oncology injectables, generic formulations, and ophthalmic and dermatology products. It offers products for various therapy areas such as cardiovascular, analgesics, genecology, cough and cold, gastroenterology, ophthalmology, anti-diabetics, orthopedic, urology and dermatological therapies. API company operates manufacturing facilities in Gujarat and Sikkim, India and research centers in Vadodara and Hyderabad, India and New Jersey, the...

  • Innovation Ranking

    $1,995 | March 2024
    Innovation Ranking

    Innovation Ranking – Aurinia Pharmaceuticals Inc

    Aurinia Pharmaceuticals Inc (Aurinia Pharmaceuticals) is a commercial-stage biopharmaceutical company. The company pipeline product includes voclosporin, lupkynis, AUR200 and AUR300. Its lupkynis is an orally administered CNI immunosuppressant, to treat adult patients with active lupus nephritis. Aurinia Pharmaceuticals voclosporin is used in clinical studies in patients with psoriasis, kidney transplantation, uveitis and dry eye syndrome indications. The company's AUR300 reduces M2 dysregulation and decreases inflammatory cytokines and finds clinical applications for autoimmune and fibrotic diseases. It collaborates with Otsuka Pharmaceutical...

  • Innovation Ranking

    $1,995 | March 2024
    Innovation Ranking

    Innovation Ranking – Sunesis Pharmaceuticals Inc

    Viracta Therapeutics Inc (Viracta Therapeutics), develops and markets cancer therapeutics for the treatment of solid and hematologic cancers. The company's pipeline products include Nana-val for the treatment of Lymphoma and Solid Tumors; SSN-510 for the treatment of hematology and solid tumors. The company had partnered programs under development include TAK-580 (formerly MLN2480) and Vosaroxin for the treatment of various types of cancer. The company entered into partnership with Biogen, Takeda, DOT Therapeutics-1, Inc, Denovo Biopharma, LLC for the development of...

  • Innovation Ranking

    $1,995 | March 2024
    Innovation Ranking

    Innovation Ranking – Vertex Pharmaceuticals Inc

    Vertex Pharmaceuticals Inc (Vertex) is a biotechnology company that discovers, develops and commercializes transformative drugs for the treatment of serious and life-threatening diseases. The company’s product portfolio includes Trikafta, Symdeko/Symkevi, Orkambi (ivacaftor/lumacaftor), and Kalydeco (ivacaftor) for the treatment of cystic fibrosis. Through its research and development efforts, the company focuses on cystic fibrosis, sickle cell diseases, beta thalassemia, type-1 diabetes and pain. It uses state-of-the-art technology platforms to discover new disease targets, compounds, delivery mechanisms, and treatment modalities. Vertex has...

  • Innovation Ranking

    $1,995 | March 2024
    Innovation Ranking

    Innovation Ranking – Amphastar Pharmaceuticals Inc

    Amphastar Pharmaceuticals Inc (Amphastar), is a specialty pharmaceutical company that develops, manufactures, and markets generic and proprietary injectable, intranasal and inhalation products. It sells insulin-active pharmaceutical ingredient products. The company’s key products include enoxaparin sodium injection; cosyntropin for injection; naloxone hydrochloride (HCl) injection and phytonadione injection; lidocaine jelly; amphadase hyaluronidase injection; epinephrine, naloxone, phytonadione, primatene mist and glucagon. Amphastar offers its products to alternate care sites, hospitals, clinics and doctors’ offices and long-term care facilities. The company markets its products...

  • Innovation Ranking

    $1,995 | March 2024
    Innovation Ranking

    Innovation Ranking – Ionis Pharmaceuticals Inc

    Ionis Pharmaceuticals Inc (Ionis), formerly ISIS Pharmaceuticals, Inc., focuses on the discovery and development of RNA-targeted drugs. The company develops medicines to treat various diseases including cancer, pulmonary, cardiovascular diseases, neurological and infectious diseases. Its major products include Spinraza for spinal muscular atrophy, Tegsedi for neuropathy and Waylivra for familial chylomicronemia syndrome. Ionis also has a pipeline of products in different phases of clinical trials. It develops products based on its proprietary antisense technology. The company partnered with other pharmaceutical...

  • Innovation Ranking

    $1,995 | March 2024
    Innovation Ranking

    Innovation Ranking – Mithra Pharmaceuticals SA

    Mithra Pharmaceuticals SA (Mithra) develops and manufactures over the counter products for women’s health and other applications. The company offers various drug products including donesta, estelle, tibelia, myring, and zoreline. Mithra offers its products in polymeric forms, hormonal tablets, and sterile injectable products. The company offers services include drug development and supporting services. It offers its products under various brands include PeriNesta, Tibelia, Estelle and Donesta. Its products are used in the treatment of contraception and fertility, gynecological infections, menopause...

  • Innovation Ranking

    $1,995 | March 2024
    Innovation Ranking

    Innovation Ranking – Fennec Pharmaceuticals Inc

    Fennec Pharmaceuticals Inc (Fennec) formerly Adherex Technologies Inc, develops drugs for cancer treatments. The company lead product candidate, Pedmark, for the prevention of cisplatin-induced hearing loss and ototoxicity in children. The company has licensing agreements with Oregon Health & Science University for development of its drug candidates. The company seeks to establish relationships with contract research organizations, universities and other institutions for development of its drug candidates. Fennec is headquartered in Durham, North Carolina, the US.

  • Innovation Ranking

    $1,995 | March 2024
    Innovation Ranking

    Innovation Ranking – Spectrum Pharmaceuticals Inc

    Spectrum Pharmaceuticals Inc (Spectrum) is a biopharma company that acquires, develops, and commercializes novel drug candidates for treatment of cancer. The company’s pipeline products include ROLONTIS, for treatment of chemotherapy-induced neutropenia helps to reduce the frequency of multiplication of tumors. This product is in phase 3 trails.; Poziotinib, an irreversible tyrosine kinase inhibitor, for non-small cell lung cancer (NSCLC) tumors with various mutations. This product is in phase 2 trials and lead candidate for the organization. The company has R&D...

Looking to stay on top of industry & market trends?

Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.